Zobrazeno 1 - 10
of 18
pro vyhledávání: '"David L. Dolinger"'
Autor:
Marco Schito, David L. Dolinger
Publikováno v:
EBioMedicine, Vol 2, Iss 10, Pp 1262-1265 (2015)
Externí odkaz:
https://doaj.org/article/0c4ce57845a24c99809d559e4ffd63ef
Autor:
Xiao-Ai Zhang, Sabrina Li, Jesus Ching, Hui-Ying Feng, Kun Yang, David L Dolinger, Long-Di Zhang, Pan-He Zhang, Wei Liu, Wu-Chun Cao
Publikováno v:
Emerging Microbes and Infections, Vol 6, Iss 1, Pp 1-3 (2017)
Emerging Microbes & Infections (2017) 6, e5; doi:10.1038/emi.2016.134; published online 18 January 2017
Externí odkaz:
https://doaj.org/article/8500b814e8e04e86bcd6deedf33833b2
Autor:
Rebecca E. Colman, Claudia M. Denkinger, Anita Suresh, David L. Dolinger, Taylor Muñoz, Timothy C. Rodwell
Publikováno v:
Diagnostic microbiology and infectious disease. 98(2)
Robust clinical specimen nucleic acid extraction instrumentation and methods are critical to the performance of downstream molecular diagnostics for the diagnosis of drug-resistant tuberculosis (DR-TB). Currently, there is a high level of interest in
Autor:
David Jamil Hadad, Renata Lyrio Peres, Bareng A. S. Nonyane, Widaad Zemanay, Mary Gaeddert, Moses Joloba, Patricia Marques-Rodrigues, Jerrold J. Ellner, Catharina Boehme, Derek T. Armstrong, Reynaldo Dietze, Mark P. Nicol, Moises Palaci, Sandra Armakovitch, David Alland, Susan E. Dorman, Shubhada Shenai, Eloise Valli, David L. Dolinger, Lydia Nakiyingi, Margareth Pretti Dalcolmo, Padmapriya P. Banada, Claudia M. Denkinger, Y.C. Manabe
Publikováno v:
Journal of Clinical Microbiology. 54:1051-1057
The Epistem Genedrive assay rapidly detects the Mycobacterium tuberculosis complex from sputum and is currently available for clinical use. However, the analytical and clinical performance of this test has not been fully evaluated. The analytical lim
Autor:
Daniela Maria Cirillo, Enrique Aviles, Matteo Zignol, Paolo Miotto, Marco Schito, Jim Gallarda, David L. Dolinger, Richard Liwski, Debra Hanna, Claudia M. Denkinger, Claudia Emerson, Angela M. Starks, Peter S. Kim
Publikováno v:
Clinical Infectious Diseases. 61:S141-S146
Continued progress in addressing challenges associated with detection and management of tuberculosis requires new diagnostic tools. These tools must be able to provide rapid and accurate information for detecting resistance to guide selection of the
Autor:
David L. Dolinger, Pamela Nabeta, Audrey Albertini, Jimena Collantes, Elena Romancenco, Belay Tessema, Eloise Valli, Nguyen Huu Lan, Claudia M. Denkinger, Nestani Tukavdze
Publikováno v:
Journal of Clinical Microbiology
The spread of multidrug-resistant (MDR) tuberculosis (TB) and extensively drug-resistant (XDR) TB hampers global efforts in the fight against tuberculosis. To enhance the development and evaluation of diagnostic tests quickly and efficiently, well-ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::582104eb91b19d82a9858884a2ce07ea
https://hdl.handle.net/20.500.12866/4660
https://hdl.handle.net/20.500.12866/4660
Autor:
Ruth McNerney, Susana Campino, Andrea M. Cabibbe, Taane G. Clark, Marco Schito, Keertan Dheda, Liezel Smith, David L. Dolinger, Camilla Rodrigues
Publikováno v:
International Journal of Infectious Diseases, Vol 56, Iss C, Pp 130-135 (2017)
Whole genome sequencing (WGS) can provide a comprehensive analysis of Mycobacterium tuberculosis mutations that cause resistance to anti-tuberculosis drugs. With the deployment of bench-top sequencers and rapid analytical software, WGS is poised to b
Autor:
Sabrina Li, Pan-He Zhang, Long-Di Zhang, Jesus Ching, Hui-Ying Feng, David L Dolinger, Xiao-Ai Zhang, Kun Yang, Wu-Chun Cao, Wei Liu
Publikováno v:
Emerging Microbes & Infections
Emerging Microbes & Infections (2017) 6, e5; doi:10.1038/emi.2016.134; published online 18 January 2017
Publikováno v:
International Journal of Mycobacteriology, Vol 5, Iss 5, Pp 27-28 (2016)
Since 2002, there has been a gradual worldwide 1.3% annual decrease in the incidence of tuberculosis (TB). This is an encouraging statistic; however, it will not achieve the World Health Organization’s goal of eliminating TB by 2050, and it is bein
Autor:
David L. Dolinger, Anne M. Whalen
Publikováno v:
Molecular Microbiology ISBN: 9781555819088
In vitro diagnostics (IVDs) are undergoing an evolution that is being driven by nucleic acid–based molecular detection technologies, from fully automated, multistep miniaturized platforms that integrate sample prep, detection, and signal amplificat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7d5625ba4531914c382ddd53e3d216f
https://doi.org/10.1128/9781555819071.ch39
https://doi.org/10.1128/9781555819071.ch39